New research led by scientists at Dana-Farber Cancer Institute, the Broad Institute, and other research centers, may offer clues to why rates of esophageal adenocarcinomas (EAC) have risen so sharply. The findings point to abnormal genes and proteins that may be lynchpins of EAC cell growth and therefore serve as targets for new therapies.
Fuente : http://www.eurekalert.org/pub_releases/2013-03/dci…
Hacer un comentario